Cargando…
Immune modulation by molecular cancer targets and targeted therapies: Rationale for novel combination strategies
Following our recent observation that alterations of the Natural Killer (NK) cell compartment in the presence of BCR-ABL-induced myeloproliferation fail to revert under targeted therapy, we discuss by what mechanisms oncogenic molecular pathways and their pharmacological inhibition may interfere wit...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3382876/ https://www.ncbi.nlm.nih.gov/pubmed/22737614 http://dx.doi.org/10.4161/onci.18401 |